INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Investors of Blue Owl Technology Finance Corp. II Who Received Shares of Blue Owl Technology Finance Corp. (NYSE: OTF), to Contact the Firm

Girard Sharp, LLP announced an investigation into potential securities claims for former Blue Owl Technology Finance Corp. II investors following the March 24, 2025 merger into Blue Owl Technology (shares issued as part of the deal). No financial results or quantified damages were provided, but the inquiry introduces potential litigation/overhang risk for affected investors.

Analysis

This is a classic litigation-overhang setup: the direct cash cost is likely secondary to the multiple effect. For a BDC/credit vehicle, the real risk is not damages per se but a wider discount to NAV, higher implied cost of equity, and reduced willingness to tap equity if growth capital is needed. That matters most over the next 1-3 months if plaintiffs file a complaint or media coverage broadens; the stock can de-rate before any economic liability is established.

Second-order, the issue can spill into peer trading even if fundamentals are unchanged. Investors often apply a small governance penalty to externally managed vehicles when merger fairness is questioned, which can pressure relative valuation versus larger, cleaner peers like ARCC or OBDC. If OTF relies on recurring capital markets access, even a modest increase in the market’s required return can slow portfolio expansion and create a negative feedback loop on fee-related earnings.

The contrarian view is that this may be mostly noise unless there is a concrete disclosure defect or a visible settlement reserve. Most of these probes never become economically meaningful versus a BDC’s recurring NII stream, so the first instinct to short into the headline may be overstated. What would falsify the bearish case: no complaint within the next few weeks, no reserve language in the next filing, and no widening versus BDC peers or NAV discount. On the other hand, any amended disclosure, director response, or insurer/settlement mention would turn this from optics into a real capital structure issue.

Key Decisions for Investors

• Relative-value short OTF vs long ARCC or OBDC over the next 1-3 months: target is modest underperformance as legal overhang widens the discount to NAV; stop if OTF outperforms peers by >5% or files a clean update with no reserve/disclosure issue.
• Do not add outright long exposure to OTF until the next quarterly filing clarifies whether management is reserving for legal costs; the risk/reward is asymmetrically poor if the market starts pricing governance discount rather than damages.
• If volatility is cheap, buy a small 1-2 month put spread on OTF rather than a naked short; the catalyst window is short, and the thesis is de-rating, not a permanent impairment to earnings power.
• Monitor the peer BDC basket (ARCC, OBDC, CSWC) for sympathy widening; if peers are sold off on no new facts, fade the move and use OTF as the cleaner relative underperformer.
• Set an alert for any complaint filing or reserve language in the next 10-Q/8-K; that would be the point to reassess for a larger 6-12 month discount-to-NAV trade.